Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study.

Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, Cameron E, Twohig KA, Pfeffer DA, Rozier JA, Gibson HS, Rao PC, Casey D, Bertozzi-Villa A, Collins EL, Dalrymple U, Gray N, Harris JR, Howes RE, Kang SY, Keddie SH, May D, Rumisha S, Thorn MP, Barber R, Fullman N, Huynh CK, Kulikoff X, Kutz MJ, Lopez AD, Mokdad AH, Naghavi M, Nguyen G, Shackelford KA, Vos T, Wang H, Smith DL, Lim SS, Murray CJL, Bhatt S, Hay SI, Gething PW.

Lancet. 2019 Jul 27;394(10195):322-331. doi: 10.1016/S0140-6736(19)31097-9. Epub 2019 Jun 19.

2.

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.

Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, Pfeffer DA, Cameron E, Rao PC, Casey D, Gibson HS, Rozier JA, Dalrymple U, Keddie SH, Collins EL, Harris JR, Guerra CA, Thorn MP, Bisanzio D, Fullman N, Huynh CK, Kulikoff X, Kutz MJ, Lopez AD, Mokdad AH, Naghavi M, Nguyen G, Shackelford KA, Vos T, Wang H, Lim SS, Murray CJL, Price RN, Baird JK, Smith DL, Bhatt S, Weiss DJ, Hay SI, Gething PW.

Lancet. 2019 Jul 27;394(10195):332-343. doi: 10.1016/S0140-6736(19)31096-7. Epub 2019 Jun 19.

3.

The effects of alcohol pricing policies on consumption, health, social and economic outcomes, and health inequality in Australia: a protocol of an epidemiological modelling study.

Jiang H, Room R, Livingston M, Callinan S, Brennan A, Doran C, Thorn M.

BMJ Open. 2019 Jun 6;9(6):e029918. doi: 10.1136/bmjopen-2019-029918.

4.

Collagenous colitis without diarrhoea at diagnosis - a follow up study.

Thörn M, Sjöberg D, Holmström T, Rönnblom A.

Scand J Gastroenterol. 2019 Feb;54(2):194-197. doi: 10.1080/00365521.2019.1570325. Epub 2019 Feb 20.

PMID:
30782025
5.

Emerging alcohol policy innovation in the Northern Territory, Australia.

Smith JA, Livingston M, Miller P, Stevens M, Griffiths K, Judd JA, Thorn M.

Health Promot J Austr. 2019 Jan;30(1):3-6. doi: 10.1002/hpja.222. No abstract available.

PMID:
30648334
6.

Addressing power and politics through action on the commercial determinants of health.

Thorn M.

Health Promot J Austr. 2018 Dec;29(3):225-227. doi: 10.1002/hpja.216. No abstract available.

PMID:
30511490
7.

malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project.

Pfeffer DA, Lucas TCD, May D, Harris J, Rozier J, Twohig KA, Dalrymple U, Guerra CA, Moyes CL, Thorn M, Nguyen M, Bhatt S, Cameron E, Weiss DJ, Howes RE, Battle KE, Gibson HS, Gething PW.

Malar J. 2018 Oct 5;17(1):352. doi: 10.1186/s12936-018-2500-5.

8.

Validation of the AAST EGS grading system for perforated peptic ulcer disease.

Hernandez MC, Thorn MJ, Kong VY, Aho JM, Jenkins DH, Bruce JL, Laing GL, Zielinski MD, Clarke DL.

Surgery. 2018 Oct;164(4):738-745. doi: 10.1016/j.surg.2018.05.061. Epub 2018 Aug 4.

PMID:
30082138
9.

The National Alcohol Strategy 2018-2026 has to become a set of commitments.

Kypri K, Thorn M, Crozier J.

Drug Alcohol Rev. 2018 Jul;37(5):563-564. doi: 10.1111/dar.12825. Epub 2018 Jun 5. Review.

PMID:
29873133
10.

Egg size and the adaptive capacity of early life history traits in Chinook salmon (Oncorhynchus tshawytscha).

Thorn MW, Morbey YE.

Evol Appl. 2017 Sep 14;11(2):205-219. doi: 10.1111/eva.12531. eCollection 2018 Feb.

11.

Queensland Alcohol-related violence and Night Time Economy Monitoring project (QUANTEM): a study protocol.

Miller PG, Ferris J, Coomber K, Zahnow R, Carah N, Jiang H, Kypri K, Chikritzhs T, Clough A, Livingston M, de Andrade D, Room R, Callinan S, Curtis A, Mayshak R, Droste N, Lloyd B, Matthews S, Taylor N, Crane M, Thorn M, Najman J.

BMC Public Health. 2017 Oct 5;17(1):789. doi: 10.1186/s12889-017-4811-9.

12.

Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure.

Collins SP, Thorn M, Nowak RM, Levy PD, Fermann GJ, Hiestand BC, Cowart TD, Venuti RP, Hiatt WR, Foo S, Pang PS.

J Clin Med. 2017 Sep 11;6(9). pii: E84. doi: 10.3390/jcm6090084.

13.

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Eriksson C, Marsal J, Bergemalm D, Vigren L, Björk J, Eberhardson M, Karling P, Söderman C; SWIBREG Vedolizumab Study Group, Myrelid P, Cao Y, Sjöberg D, Thörn M, Karlén P, Hertervig E, Strid H, Ludvigsson JF, Almer S, Halfvarson J.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):722-729. doi: 10.1080/00365521.2017.1304987. Epub 2017 Mar 31.

PMID:
28362144
14.

Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.

Angelison L, Almer S, Eriksson A, Karling P, Fagerberg U, Halfvarson J, Thörn M, Björk J, Hindorf U, Löfberg R, Bajor A, Hjortswang H, Hammarlund P, Grip O, Torp J, Marsal J, Hertervig E; Swedish Organization for the Study of Inflammatory Bowel diseases (SOIBD).

Aliment Pharmacol Ther. 2017 Feb;45(4):519-532. doi: 10.1111/apt.13893. Epub 2016 Dec 27.

15.

Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials.

Harris SC, Morganroth J, Ripa SR, Thorn MD, Colucci S.

Postgrad Med. 2017 Jan;129(1):69-80. doi: 10.1080/00325481.2017.1270156.

PMID:
27927048
16.

Clinical course of Crohn's disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009.

Rönnblom A, Holmström T, Karlbom U, Tanghöj H, Thörn M, Sjöberg D.

Scand J Gastroenterol. 2017 Jan;52(1):81-86. doi: 10.1080/00365521.2016.1230777. Epub 2016 Sep 15.

PMID:
27632773
17.

Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.

Rönnblom A, Holmström T, Tanghöj H, Karlbom U, Thörn M, Sjöberg D.

Scand J Gastroenterol. 2016 Nov;51(11):1339-44. doi: 10.1080/00365521.2016.1200141. Epub 2016 Jun 29.

PMID:
27356846
18.

Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.

Thorn M, Guha P, Cunetta M, Espat NJ, Miller G, Junghans RP, Katz SC.

Cancer Gene Ther. 2016 Jun;23(6):188-98. doi: 10.1038/cgt.2016.19. Epub 2016 May 20.

PMID:
27199222
19.

Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study (.).

Thörn M, Rorsman F, Rönnblom A, Sangfelt P, Wanders A, Eriksson BM, Bondeson K.

Scand J Gastroenterol. 2016 Sep;51(9):1075-80. doi: 10.3109/00365521.2016.1156154. Epub 2016 May 4.

PMID:
27142339
20.

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery.

Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP.

Cancer Gene Ther. 2016 May;23(5):142-8. doi: 10.1038/cgt.2016.14. Epub 2016 Apr 15.

21.

Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model.

Atkinson SM, Bleil J, Maier R, Kühl AA, Thorn M, Serikawa K, Fox B, Kruse K, Haase C, Skov S, Nansen A, Syrbe U.

Arthritis Res Ther. 2016 Jan 23;18:28. doi: 10.1186/s13075-016-0931-3.

22.

Evidence for the secondary sexual development of the anal fin in female kokanee salmon Oncorhynchus nerka.

Thorn MW, Morbey YE.

J Fish Biol. 2016 Feb;88(2):448-58. doi: 10.1111/jfb.12800. Epub 2015 Oct 28.

PMID:
26506902
24.

Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.

Morganroth J, Wang Y, Thorn M, Kumagai Y, Harris S, Stockbridge N, Kleiman R, Shah R.

Br J Clin Pharmacol. 2015 Sep;80(3):446-59. doi: 10.1111/bcp.12684. Epub 2015 Jul 2.

25.

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR, Khare PD, Thorn M, Ma Q, Stainken BF, Assanah EO, Davies R, Espat NJ, Junghans RP.

Clin Cancer Res. 2015 Jul 15;21(14):3149-59. doi: 10.1158/1078-0432.CCR-14-1421. Epub 2015 Apr 7.

26.

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA, DeMatteo RP, Ayala A, Joseph Espat N, Junghans RP, Katz SC.

Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8.

27.

A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.

Litwin JS, Benedict MS, Thorn MD, Lawrence LE, Cammarata SK, Sun E.

Antimicrob Agents Chemother. 2015;59(6):3469-73. doi: 10.1128/AAC.04813-14. Epub 2015 Apr 6.

28.

Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis.

Morrow GR, Schwartzberg L, Barbour SY, Ballinari G, Thorn MD, Cox D.

J Community Support Oncol. 2014 Jul;12(7):250-8. doi: I 10.12788/jcso.0058.

29.

Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats.

Thorn M, Hudson AW, Kreeger J, Kawabe TT, Bowman CJ, Collinge M.

J Immunotoxicol. 2015;12(4):350-60. doi: 10.3109/1547691X.2014.980925. Epub 2014 Nov 21.

PMID:
25412622
30.

Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases.

Saied A, Licata L, Burga RA, Thorn M, McCormack E, Stainken BF, Assanah EO, Khare PD, Davies R, Espat NJ, Junghans RP, Katz SC.

Cancer Gene Ther. 2014 Nov;21(11):457-62. doi: 10.1038/cgt.2014.50. Epub 2014 Oct 3.

31.

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Thorn M, Point GR, Burga RA, Nguyen CT, Joseph Espat N, Katz SC.

J Leukoc Biol. 2014 Nov;96(5):883-94. doi: 10.1189/jlb.3A0114-012RR. Epub 2014 Aug 1.

32.

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).

Schwartzberg L, Barbour SY, Morrow GR, Ballinari G, Thorn MD, Cox D.

Support Care Cancer. 2014 Feb;22(2):469-77. doi: 10.1007/s00520-013-1999-9. Epub 2013 Oct 19.

33.
34.

Impact of oncology drug shortages on patient therapy: unplanned treatment changes.

Becker DJ, Talwar S, Levy BP, Thorn M, Roitman J, Blum RH, Harrison LB, Grossbard ML.

J Oncol Pract. 2013 Jul;9(4):e122-8. doi: 10.1200/JOP.2012.000799. Epub 2013 Mar 19.

35.

Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer.

Dinkel J, Khalilzadeh O, Hintze C, Fabel M, Puderbach M, Eichinger M, Schlemmer HP, Thorn M, Heussel CP, Thomas M, Kauczor HU, Biederer J.

Lung Cancer. 2013 Oct;82(1):76-82. doi: 10.1016/j.lungcan.2013.07.006. Epub 2013 Aug 8.

PMID:
23932487
36.

Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC.

J Leukoc Biol. 2013 Oct;94(4):813-23. doi: 10.1189/jlb.0313137. Epub 2013 Jul 24.

37.

Microscopic colitis in Uppsala health region, a population-based prospective study 2005-2009.

Thörn M, Sjöberg D, Ekbom A, Holmström T, Larsson M, Nielsen AL, Holmquist L, Thelander U, Wanders A, Rönnblom A.

Scand J Gastroenterol. 2013 Jul;48(7):825-30. doi: 10.3109/00365521.2013.800993. Epub 2013 May 31.

PMID:
23721118
38.

Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study.

Edwards J, Sperry V, Adams MH, Gallipoli S, Thorn MD, Longstreth J, Boinpally R.

Int J Clin Pharmacol Ther. 2013 Jun;51(6):456-65. doi: 10.5414/CP201826.

PMID:
23611569
39.

Atypical femoral fractures related to bisphosphonate therapy.

Jain TP, Thorn M.

Indian J Radiol Imaging. 2012 Jul;22(3):178-81. doi: 10.4103/0971-3026.107178.

40.

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor.

Katz SC, Burga RA, Naheed S, Licata LA, Thorn M, Osgood D, Nguyen CT, Espat NJ, Fletcher JA, Junghans RP.

J Transl Med. 2013 Feb 21;11:46. doi: 10.1186/1479-5876-11-46.

41.

Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments.

Collinge M, Thorn M, Peachee V, White K Jr.

J Immunotoxicol. 2013 Oct-Dec;10(4):341-8. doi: 10.3109/1547691X.2012.747232. Epub 2013 Jan 3.

PMID:
23282408
42.

Embryo-fetal transfer of bevacizumab (Avastin) in the rat over the course of gestation and the impact of neonatal Fc receptor (FcRn) binding.

Thorn M, Piche-Nicholas N, Stedman D, Davenport SW, Zhang N, Collinge M, Bowman CJ.

Birth Defects Res B Dev Reprod Toxicol. 2012 Oct;95(5):363-75. doi: 10.1002/bdrb.21026. Epub 2012 Sep 11.

PMID:
22969064
43.

Cap polyposis mistaken for Crohn's disease: case report and review of literature.

Kini GP, Murray I, Champion-Young J, Lau M, Katta V, Thorn M, Schultz MP.

J Crohns Colitis. 2013 Apr;7(3):e108-11. doi: 10.1016/j.crohns.2012.06.005. Epub 2012 Jul 4. Review.

PMID:
22766527
44.

First record of Aedes japonicus japonicus in Mississippi.

Thorn M, Varnado WC, Goddard J.

J Am Mosq Control Assoc. 2012 Mar;28(1):43-4.

PMID:
22533083
45.

Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer.

Mozley PD, Bendtsen C, Zhao B, Schwartz LH, Thorn M, Rong Y, Zhang L, Perrone A, Korn R, Buckler AJ.

Transl Oncol. 2012 Feb;5(1):19-25. Epub 2012 Feb 1.

46.

Laparoscopic cholecystectomy through the umbilicus--minimal access surgery gets more minimal.

Lord I, Page B, Thorn M, Thompson-Fawcett M.

N Z Med J. 2011 Aug 26;124(1341):50-7. Review.

PMID:
21959636
47.

NZ Medical Council's position on the Four Principles.

Thorn M.

J Prim Health Care. 2011 Sep 1;3(3):254. No abstract available.

PMID:
21892437
48.

Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.

Sherif AM, Eriksson E, Thörn M, Vasko J, Riklund K, Ohberg L, Ljungberg BJ.

BJU Int. 2012 Apr;109(8):1134-9. doi: 10.1111/j.1464-410X.2011.10444.x. Epub 2011 Aug 24.

49.

Evidence for immunosurveillance in intestinal premalignant lesions.

Karlsson M, Lindberg K, Karlén P, Ost A, Thörn M, Winqvist O, Eberhardson M.

Scand J Immunol. 2010 May;71(5):362-8. doi: 10.1111/j.1365-3083.2010.02377.x.

50.

Enhancement of anhydrous proton transport by supramolecular nanochannels in comb polymers.

Chen Y, Thorn M, Christensen S, Versek C, Poe A, Hayward RC, Tuominen MT, Thayumanavan S.

Nat Chem. 2010 Jun;2(6):503-8. doi: 10.1038/nchem.629. Epub 2010 Apr 25.

PMID:
20489721

Supplemental Content

Support Center